Story Navigation
-
Access to HealthcareCOVID-19Infectious DiseasesInnovationWorking at NovartisStreamlining systems to respond to COVID-19
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
Access to Healthcare -
DiscoveryCOVID-19Disease EradicationInfectious DiseasesWorking at NovartisClinical ResearchClinical TrialsMoving from speculation to science during a pandemic
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
Discovery -
DiscoveryCOVID-19Disease EradicationInfectious DiseasesWorking at NovartisScientific ResearchIt takes an R&D village to fight a pandemic
Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Discovery -
From Our LabsCOVID-19Disease EradicationInnovationScientific ResearchA visual tour of scientific strategies for combating coronavirus
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
From Our Labs -
People and CultureCOVID-19DigitalClinical ResearchClinical TrialsClinical ScienceDrug DevelopmentGoing the extra mile to keep clinical trials on track during the COVID-19 pandemic
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
People and Culture -
DiscoveryBiomedical ResearchCOVID-19Data ScienceDiseasesInfectious DiseasesClinical TrialsBiomedical ScienceCOVID-19: Answering your top questions
Novartis CEO Vas Narasimhan answers questions about COVID-19.
Discovery -
DiscoveryDrug DesignInnovationNovartis Institutes for BioMedical ResearchScientific ResearchVisualizing molecular glues
Molecular glues are a new type of medicine inspired by nature’s matchmakers.
Discovery -
Patient PerspectivesDisease AwarenessDiseasesHeart FailurePatient VoicesDrug DevelopmentCaring for someone with heart failure
Caring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.
Patient Perspectives -
Data ScienceDigitalEmerging TechnologyFuture of HealthcareInnovationThe data42 program shows Novartis’ intent to go big on data and digital
Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.
-
DiscoveryData ScienceDigitalEmerging TechnologyFuture of HealthcareInnovationMeet Achim, leading the data42 program
The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
Discovery -
People and CultureLocal ImpactNovartis AccessNovartis Social BusinessWorking at NovartisCareersNovartis Social Business Careers: improving health in lower income countries
This is the story of how three Novartis colleagues took a career decision to improve health in lower income countries.
People and Culture -
From Our LabsDrug DiscoveryEmerging TechnologyInnovationNovartis Institutes for BioMedical ResearchPostdoc ProgramAdvancing medicine through collaboration
In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.
From Our Labs
Pagination
- ‹ Previous page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- …
- 32
- › Next page